Trial site
Carteret Medical Group
- 12running trials
- 12closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes14 trials
- Obesity11 trials
- Chronic kidney disease5 trials
- Alzheimer disease3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Obstructive sleep apnoea2 trials
- Type 1 diabetes2 trials
- High blood pressure1 trial
- Osteoarthritis1 trial
- Phase
- Phase 321 trials
- Phase 22 trials
- Status
- Completed12 trials
- Active, not recruiting7 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Novo Nordisk A/S12 trials
- Eli Lilly and Company9 trials
- Amgen1 trial
- Mineralys Therapeutics Inc.1 trial
- Target PharmaSolutions, Inc.1 trial
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes3 recruiting
- Obesity2 recruiting
- Chronic kidney disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026